Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cell Chemical Biology|February 7, 2023
Piperlongumine conjugates induce targeted protein degradationJing Pei, Yufeng Xiao, Xingui Liu, et al.Blood|May 16, 2018
CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemiaHuacheng Luo, Fei Wang, Jie Zha, et al.Molecular Cancer Therapeutics|October 20, 2021
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216Dinesh Thummuri, Sajid Khan, Patrick W Underwood, et al.Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.Blood|July 24, 2024
KDM6A regulates immune response genes in multiple myelomaDaphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, et al.Biorxiv : the Preprint Server for Biology|February 26, 2024
KDM6A Regulates Immune Response Genes in Multiple MyelomaDaphne Dupéré-Richer, Alberto Riva, Sayantan Maji, et al.Cell Reports|August 17, 2022
Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancerPriyanka Gupta, Keehn Strange, Rahul Telange, et al.Blood|April 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenomeAmin Sobh, Elena Encinas, Alisha Patel, et al.Journal of the American Chemical Society|March 28, 2023
Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2Ronan P Hanley, David Y Nie, John R Tabor, et al.Biorxiv : the Preprint Server for Biology|February 13, 2026
Selective Glucocorticoid Receptor Modulators of Immune Checkpoint FunctionRobin R Kobylski, Charles K Min, Jerome C Nwachukwu, et al.Pageof 3